c1_bannerpc.jpg c1_bannerph.jpg

Launched Drug

MESALAMINE Delayed Release Tablet
meishala.png
  • 【Strength】 1.2g
  • 【Approved Regions】: the United Sate

【Indication】: induction and maintenance of remission in adult patients with mildly to moderately active ulcerative colitis

For more information, please refer to the manua


POSACONAZOLE delayed-release tablets
bosha001-102.jpg
22.jpg
33.jpg
bosha004-804.jpg
  • The first generic drug approved in China and the U.S.
  • A new generation of triazole antifungal drugs
  • 【Approved Regions】:China、 the United States、 Australia、Singapore 、 Saudi Arabia、Canada

【Strength】100mg

【Indication】Prophylaxis of invasive Aspergillus and Candida Infections

For more information, please refer to the manua

URSODEOXYCHOLIC ACID capsules
xiongquyang001-50.jpg
  • 【Strength】250mg
  • 【Approved Regions】:China

【Therapeutic field】Digestive liver and gallbladder

For more information, please refer to the manua

BUPROPION HYDROCHLORIDE extended-release tablets
anfeitatong-384.jpg
anfei.jpg
  • 【Strength】150 mg, 300 mg
  • 【Approved Regions】:China、 the United States

【INDICATION】• treatment of major depressive disorder (MDD) • prevention of seasonal affective disorder (SAD)

For more information, please refer to the manua

PAROXETINE extended-release tablets
paluo001-513.jpg
  • 【Strength】12.5mg, 25mg
  • 【Approved Regions】:China、 the United States

【INDICATION】 Paroxetine extended-release tablets are a selective serotonin reuptake inhibitor (SSRI) indicated in adults for the treatment of : • Major Depressive Disorder (MDD) • Panic Disorder (PD) • Social Anxiety Disorder (SAD)

For more information, please refer to the manua

SEVELAMER CARBONATE tablets
siweilamu001-58.png
  • 【Strength】800mg
  • 【Approved Regions】: the United States

【Indication】 indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis

For more information, please refer to the manua


PROPAFENONE HYDROCHLORIDE extended-release capsules
puluo1.jpg
  • 【Strength】 225 mg, 325 mg, 425 mg
  • 【Approved Regions】: the United States

【Indication】Propafenone hydrochloride extended-release capsules is an antiarrhythmic indicated to prolong the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic (most likely paroxysmal or persistent) AF who do not have structural heart disease.

For more information, please refer to the manual.

Pending Approvals

Shanghai Head Office

99 Haike Road, Bldg. 3, 1st Flr., Pudong District Shanghai 201210, P.R. China

Manufacturing Site in Jiangsu

No. 163 Zhuhai Road, Haimen Area, Nantong City, Jiangsu Province

Copyright © 2014-2022 SINOTHERAPEUTICS.COM ICP:13048014-1   Powered by Yongsy

Privacy Legal